高度近视合并白内障患者超声乳化植入晶体术后的疗效观察

目的评价超声乳化白内障摘除联合人工晶体植入术在治疗高度近视合并白内障患者中的临床疗效。方法收集2008年3月～2011年10月武进人民医院眼科高度近视的老年性合并白内障患者67例(80眼),年龄40～86岁,平均66.4岁,行角膜缘隧道切口超声乳化吸除。77眼通过3.2mm切口植入折叠式或非球面人工晶体,3眼通过5.5mm切口植入PMMA硬性人工晶体。植入的人工晶体屈光度为0.00～+10.0(平均5.68)D。使用SPSS 14.0统计分析所有患者术后1月视力情况。结果术后未见明显严重并发症。95.0%患者术后1月视力明显提高,仅有4人裸眼视力<0.1。结论超声乳化白内障摘除加人工晶体植入术是治疗高度近视合并白内障患者的一种安全、有效的方法。

Observation about the Clinical Efficacy of Intraocular Lens(IOL) Implantation and Phacoemulsification on High Myopia Patients with Cataract

Objective To evaluate the clinical efficacy of phacoemulsification and intraocular lens(IOL) implantation on high myopia patients with cataract. Methods From March 2008 to October 2011,67 high myopia old patients(80 eyes) with cataract were selected in Wujin People’s Hospital.The age range was from 40 to 86(mean 66.4) years.All subjects were done with a scleral tunnel incision.77 eyes were treated with phacoemulsification and folding or non-spherical IOL implantation through a 3.2mm incision,3 eyes were treated with phacoemulsification and hard polymethyl methacrylate(PMMA) IOL implantation through a 5.5mm incision.The diopter of IOL was from +0.00 D to +10.0D(mean 5.68D).The visual acuity one month after surgery was recorded and SPSS 14.0 software was used to analyze the database. Results All subjects had no serious complications after surgery,and 95.0% patients’ visual acuity were evidently improved,only four patients’ uncorrected visual acuity less than 0.1. Conclusions Phacoemulsification and intraocular lens implantation is a safe and effective therapeutic approach in high myopia patients with cataract.